A Long-term Follow-up Study for Cardiac Safety in the Patients With HER2 (+) Breast Cancer Who Have Completed the SB3-G31-BC

Clinical trial NCT02771795 · TERMINATED

Trial details

NCT number: NCT02771795
Sponsor: Samsung Bioepis Co., Ltd.
Status: TERMINATED
Study type: OBSERVATIONAL

Breast Neoplasms

Start date: 2016-04-01
Primary completion: 2020-12-01
Enrollment: 538

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.